novo nordisk semaglutide products and competitors Drugmaker slashes Wegovy sales forecasts, blaming compounding Wegovy-maker Novo Nordisk ousted CEO

Ozempic, on the other hand, contains a GLP-1 receptor agonist

The clinical principle is start low and go slow. Your dose should escalate based on how you are tolerating it, not on a manufacturers pre-set schedule

The cirrhosis caused by NASH can raise the risk of other severe complications, including hepatocellular carcinoma (the most common form of primary liver cancer) and outright liver failure

Statutes of limitations are state-specific and may be affected by the date your injury was discovered

In 2020 and 2021, Novo Nordisk announced the results of five phase-three trials involving the Semaglutide Treatment Effect in People (STEP)

Semaglutide also slows digestion, which keeps you feeling satisfied longer and helps prevent overeating